Publications by authors named "Walker M Schmidt"
Article Synopsis
- Financial toxicity refers to the economic burden and financial hardships faced by patients, particularly those with plasma cell disorders.
- It negatively impacts patients' ability to access necessary treatments and medications.
- This issue affects their overall well-being and can lead to stress and anxiety related to health care costs.
Allogeneic stem cell transplant (allo SCT) for multiple myeloma (MM) is potentially curative in some, while toxic in many others. We retrospectively analyzed 85 patients diagnosed with MM who underwent allo SCT as frontline or salvage therapy between 2000 and 2022 at Mayo Clinic Rochester and examined patient outcomes and prognostic markers. Overall survival (OS), progression free survival (PFS), treatment related mortality (TRM), and relapse rates (RR) were estimated using the Kaplan Meier method and competing risk models.
View Article and Find Full Text PDFBackground: Female underrepresentation in oncology clinical trials can result in outcome disparities. We evaluated female participant representation in US oncology trials by intervention type, cancer site, and funding.
Materials And Methods: Data were extracted from the publicly available Aggregate Analysis of ClinicalTrials.
Purpose: The study aims to evaluate the risk factors and incidence of thromboembolic events among adult women with cancer who underwent controlled ovarian hyperstimulation (COH) for fertility preservation.
Methods: Retrospective, descriptive cohort analysis of patient demographics, medical history, cancer type/treatment, laboratory values, thrombosis within 6 months of COH.
Results: 4 of 127 study participants experienced a venous thromboembolic event within 6 months of COH.